A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes. (2022)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers14133257
PubMed Identifier: 35805029
Publication URI: http://europepmc.org/abstract/MED/35805029
Type: Journal Article/Review
Volume: 14
Parent Publication: Cancers
Issue: 13
ISSN: 2072-6694